{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:01:35Z","timestamp":1790715695026,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["CPU2022QZ16"],"award-info":[{"award-number":["CPU2022QZ16"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.heliyon.2024.e26209","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:44:49Z","timestamp":1707871489000},"page":"e26209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A sensitive and specific LC\u2013MS\/MS method for determination of a novel antihypertensive peptide FR-6 in rat plasma and pharmacokinetic study"],"prefix":"10.1016","volume":"10","author":[{"given":"Yu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyue","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-6673","authenticated-orcid":false,"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26209_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future Health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e26209_bib2","article-title":"Overview of the angiotensin-converting-enzyme inhibitors","volume":"57","author":"Piepho","year":"2000","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.heliyon.2024.e26209_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-2621.2003.tb09635.x","article-title":"Functional and bioactive properties of quinoa seed protein hydrolysates","volume":"68","author":"Aluko","year":"2003","journal-title":"J. Food Sci."},{"key":"10.1016\/j.heliyon.2024.e26209_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.foodchem.2015.02.004","article-title":"Rapid purification and characterization of angiotensin converting enzyme inhibitory peptides from lizard fish protein hydrolysates with magnetic affinity separation","volume":"182","author":"Lan","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.heliyon.2024.e26209_bib5","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/acs.jafc.0c07048","article-title":"Transport, in vivo antihypertensive effect, and pharmacokinetics of an angiotensin-converting enzyme (ACE) inhibitory peptide LVLPGE","volume":"69","author":"Pei","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2024.e26209_bib6","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1021\/acs.jafc.9b01137","article-title":"In vitro and in vivo studies on the angiotensin-converting enzyme inhibitory activity peptides isolated from broccoli protein hydrolysate","volume":"67","author":"Dang","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2024.e26209_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijbiomac.2022.01.114","article-title":"Exploration of interaction between angiotensin I-converting enzyme (ACE) and the inhibitory peptide from Wakame (Undaria pinnatifida)","volume":"204","author":"Feng","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e26209_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700732","article-title":"A novel antihypertensive peptide identified in thermolysin-digested rice bran","volume":"62","author":"Shobako","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2024.e26209_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2019.125161","article-title":"Quinoa protein: composition, structure and functional properties","volume":"299","author":"Dakhili","year":"2019","journal-title":"Food Chem."},{"key":"10.1016\/j.heliyon.2024.e26209_bib10","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1080\/10408398.2021.1982860","article-title":"Exploration on bioactive properties of quinoa protein hydrolysate and peptides: a review","volume":"63","author":"Guo","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2024.e26209_bib11","series-title":"In Vivo Antihypertension, and Molecular Docking","first-page":"24","article-title":"Isolation of novel ACE-inhibitory and antioxidant peptides from quinoa bran albumin assisted with an in silico approach: characterization","author":"Zheng","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e26209_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1015863507496","article-title":"The disposition of a human relaxin (hRlx-2) in pregnant and nonpregnant rats","volume":"9","author":"Cossum","year":"1992","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.heliyon.2024.e26209_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4155\/bio-2022-0141","article-title":"Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum","volume":"14","author":"Idowu","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.heliyon.2024.e26209_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bio.953","article-title":"The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging","volume":"22","author":"Brutkiewicz","year":"2007","journal-title":"Luminescence"},{"key":"10.1016\/j.heliyon.2024.e26209_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138920009789895499","article-title":"Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies","volume":"10","author":"Lin","year":"2009","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.heliyon.2024.e26209_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1570-0232(02)00536-6","article-title":"Quantitative analysis of a model opioid peptide and its cyclic prodrugs in rat plasma using high-performance liquid chromatography with fluorescence and tandem mass spectrometric detection","volume":"780","author":"Yang","year":"2002","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e26209_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpba.2005.01.024","article-title":"Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS\/MS","volume":"38","author":"Chang","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26209_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpba.2018.12.036","article-title":"UPLC-MS\/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma","volume":"166","author":"Xu","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26209_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2016.02.034","article-title":"Simultaneous determination of mangiferin and neomangiferin in rat plasma by UPLC\u2013MS\/MS and its application for pharmacokinetic study","volume":"124","author":"Qiu","year":"2016","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26209_bib20","article-title":"In vivo pharmacokinetic drug-drug interaction studies between fedratinib and antifungal agents based on a newly developed and validated UPLC\/MS-MS method","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26209_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/13880209.2022.2048862","article-title":"Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC-MS\/MS assay","volume":"60","author":"Zhang","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2024.e26209_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0888-7543(91)90154-7","article-title":"The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26","volume":"11","author":"Allderdice","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.heliyon.2024.e26209_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bst0180185","article-title":"The fructose-1,6-bisphosphate aldolases: same reaction, different enzymes","volume":"18","author":"Perham","year":"1990","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.heliyon.2024.e26209_bib24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00018-005-4533-5","article-title":"Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development","volume":"62","author":"Jeon","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e26209_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170573","article-title":"Hypotensive peptides derived from plant proteins","volume":"142","author":"Shobako","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.heliyon.2024.e26209_bib26","article-title":"Recent findings on the cellular and molecular mechanisms of action of novel food-derived antihypertensive peptides","volume":"4","author":"Okagu","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.heliyon.2024.e26209_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126403","article-title":"Role of insulin in Health and disease: an update","volume":"22","author":"Rahman","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024022400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024022400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:05:16Z","timestamp":1790712316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024022400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2405844024022400"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26209","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive and specific LC\u2013MS\/MS method for determination of a novel antihypertensive peptide FR-6 in rat plasma and pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26209"}}